Cargando…
Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225867/ https://www.ncbi.nlm.nih.gov/pubmed/31693161 http://dx.doi.org/10.1093/ehjcvp/pvz067 |
_version_ | 1783534159832023040 |
---|---|
author | Gorosabel, Maria C Dubacher, Nicolo Meienberg, Janine Matyas, Gabor |
author_facet | Gorosabel, Maria C Dubacher, Nicolo Meienberg, Janine Matyas, Gabor |
author_sort | Gorosabel, Maria C |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7225867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72258672020-05-19 Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? Gorosabel, Maria C Dubacher, Nicolo Meienberg, Janine Matyas, Gabor Eur Heart J Cardiovasc Pharmacother Correspondence Oxford University Press 2020-05 2019-11-06 /pmc/articles/PMC7225867/ /pubmed/31693161 http://dx.doi.org/10.1093/ehjcvp/pvz067 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Correspondence Gorosabel, Maria C Dubacher, Nicolo Meienberg, Janine Matyas, Gabor Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
title | Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
title_full | Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
title_fullStr | Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
title_full_unstemmed | Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
title_short | Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
title_sort | vascular ehlers–danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol? |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225867/ https://www.ncbi.nlm.nih.gov/pubmed/31693161 http://dx.doi.org/10.1093/ehjcvp/pvz067 |
work_keys_str_mv | AT gorosabelmariac vascularehlersdanlossyndromecanthebeneficialeffectofceliprololbeextrapolatedtobisoprolol AT dubachernicolo vascularehlersdanlossyndromecanthebeneficialeffectofceliprololbeextrapolatedtobisoprolol AT meienbergjanine vascularehlersdanlossyndromecanthebeneficialeffectofceliprololbeextrapolatedtobisoprolol AT matyasgabor vascularehlersdanlossyndromecanthebeneficialeffectofceliprololbeextrapolatedtobisoprolol |